An immunotherapeutic strategy for prolonging graft survival in mice
Tài liệu tham khảo
Belli, 2014, Preoperative risk factors predict survival following cardiac retransplantation: analysis of the United Network for Organ Sharing database, J. Thorac. Cardiovasc. Surg., 147, 1972, 10.1016/j.jtcvs.2014.02.013
Organ Procurement and Transplantation Network (OPTN) Data. Available at: <http://optn.transplant.hrsa.gov/>Retrieved 13 Aug 2014.
Lakkis, 2003, Cells: a hurdle to immunologic tolerance, J. Am. Soc. Nephrol., 14, 2402, 10.1097/01.ASN.0000085020.78117.70
Valujskikh, 2003, In remembrance of things past: memory T cells and transplant rejection, Immunol. Rev., 196, 65, 10.1046/j.1600-065X.2003.00087.x
Valujskikh, 2007, Frontiers in nephrology: T cell memory as a barrier to transplant tolerance, J. Am. Soc. Nephrol., 18, 2252, 10.1681/ASN.2007020151
Heeger, 1999, Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes, J. Immunol., 163, 2267, 10.4049/jimmunol.163.4.2267
Macedo, 2009, Contribution of naive and memory T-cell populations to the human alloimmune response, Am. J. Transplant., 9, 2057, 10.1111/j.1600-6143.2009.02742.x
Kupiec-Weglinski, 1996, Graft rejection in sensitized recipients, Ann. Transplant., 1, 34
Liang H, Zhao Y, San Z, Liao C, Sha C, Xie B, et al. The recall alloresponse following retransplantation is more intense compared with the T cell memory-transfer model. Immunol. Investig. 2010;39:39–53.
Minamimura, 2008, Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice, Am. J. Transplant., 8, 761, 10.1111/j.1600-6143.2007.02143.x
Xia, 2010, Suppressing memory T cell activation induces islet allograft tolerance in alloantigen-primed mice, Transpl. Int., 23, 1154, 10.1111/j.1432-2277.2010.01106.x
Xiao, 2011, New insights on OX40 in the control of T cell immunity and immune tolerance in vivo, J. Immunol., 188, 892, 10.4049/jimmunol.1101373
Yuan, 2003, The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo, J. Immunol., 170, 2949, 10.4049/jimmunol.170.6.2949
Wang, 2014, Memory T cells mediate cardiac allograft vasculopathy and are inactivated by anti-OX40L monoclonal antibody, Cardiovasc. Drugs Ther., 28, 115, 10.1007/s10557-013-6502-9
Ge, 2010, Regulatory T cells are critical to tolerance induction in presensitized mouse transplant recipients through targeting memory T cells, Am. J. Transplant., 10, 1760, 10.1111/j.1600-6143.2010.03186.x
Vu, 2006, Critical, but conditional, role of OX40 in memory T cell-mediated rejection, J. Immunol., 176, 1394, 10.4049/jimmunol.176.3.1394
Fu, 2013, Late-onset hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation in patients with advanced leukemia: differences in ATG dosage are key, Int. J. Hematol., 98, 89, 10.1007/s12185-013-1350-8
Kute, 2012, Post-renal transplant cytomegalovirus infection: study of risk factors, Transplant. Proc., 44, 706, 10.1016/j.transproceed.2011.12.025
Emin, 2011, Antithymocyte globulin induction therapy for adult heart transplantation: a UK national study, J. Heart Lung Transplant., 30, 770, 10.1016/j.healun.2011.01.716
Gao, 2013, Pretransplant infusion of donor B cells enhances donor-specific skin allograft survival, PLoS One, 8, 10.1371/journal.pone.0077761
Sun, 2013, Adoptive infusion of tolerance dendritic cells prolongs survival of small intestine allografts in rats: systematic review and meta-analysis, J. Evid. Based Med., 6, 185, 10.1111/jebm.12050
Wekerle, 2002, Mechanisms of transplant tolerance induction using costimulatory blockade, Curr. Opin. Immunol., 14, 592, 10.1016/S0952-7915(02)00378-3
Quezada, 2003, Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation, Blood, 102, 1920, 10.1182/blood-2003-02-0586
Tanigawa, 1999, Injection of mitomycin-C-treated spleen cells induces donor-specific unresponsiveness to cardiac allografts in rats, Transplantation, 67, 653, 10.1097/00007890-199903150-00003
Terness, 2009, Mitomycin C-treated antigen-presenting cells as a tool for control of allograft rejection and autoimmunity: from bench to bedside, Hum. Immunol., 70, 506, 10.1016/j.humimm.2009.04.024
Liu, 2014, Pretreatment of transfused donor splenocytes and allografts with mitomycin C attenuates acute rejection in heart transplantation in mice, Transplant. Proc., 46, 1169, 10.1016/j.transproceed.2013.11.052
Li, 2002, Pretreatment of recipients with mitomycin-C-treated dendritic cells induces significant prolongation of cardiac allograft survival in mice, Transplant. Proc., 34, 3426, 10.1016/S0041-1345(02)03681-3
Rosborough, 2013, Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction, Blood, 121, 3619, 10.1182/blood-2012-08-448290
Cortazar, 2011, Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin, Am. J. Transplant., 12, 379, 10.1111/j.1600-6143.2011.03826.x
Hester, 2012, Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo, Am. J. Transplant., 12, 2008, 10.1111/j.1600-6143.2012.04065.x
Singh, 2009, Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naive CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro, Transplant. Proc., 41, 418, 10.1016/j.transproceed.2008.10.079
Ma, 2009, Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice, Int. Immunopharmacol., 9, 553, 10.1016/j.intimp.2009.01.033
Preston, 2005, IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates, Am. J. Transplant., 5, 1032, 10.1111/j.1600-6143.2005.00796.x
Xiong, 2012, Flt3L combined with rapamycin promotes cardiac allograft tolerance by inducing regulatory dendritic cells and allograft autophagy in mice, PLoS One, 7, 10.1371/journal.pone.0046230
Dhanireddy, 2009, Portal venous donor-specific transfusion in conjunction with sirolimus prolongs renal allograft survival in nonhuman primates, Am. J. Transplant., 9, 124, 10.1111/j.1600-6143.2008.02448.x
Boyle, 1998, Intrasplenic liver parenchymal cells in conjunction with low-dose rapamycin and cyclosporine induce a unique and specific prolongation of rat cardiac and small bowel allograft survival, Cell Transplant., 7, 247, 10.1016/S0963-6897(97)00158-9
Stanojlovic, 2010, Influence of combined treatment of low dose rapamycin and cyclosporin a on corneal allograft survival, Graefes Arch. Clin. Exp. Ophthalmol., 248, 1447, 10.1007/s00417-010-1420-z
Matsuura, 1991, Simplified mouse cervical heart transplantation using a cuff technique, Transplantation, 51, 896, 10.1097/00007890-199104000-00031
Billingham, 1990, A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group. The International Society for Heart Transplantation, J. Heart Transplant., 9, 587
Winters, 1998, The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary, J. Heart Lung Transplant., 17, 754
Lo, 2013, Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion, Am. J. Transplant., 13, 320, 10.1111/j.1600-6143.2012.04342.x
Taylor, 2004, Heterologous immunity and homeostatic proliferation as barriers to tolerance, Curr. Opin. Immunol., 16, 558, 10.1016/j.coi.2004.07.007
Page, 2009, Memory T-cell-specific therapeutics in organ transplantation, Curr. Opin. Organ Transplant., 14, 643, 10.1097/MOT.0b013e328332bd4a
Gordon, 2014, Regulatory dendritic cells for immunotherapy in immunologic diseases, Front. Immunol., 5, 7, 10.3389/fimmu.2014.00007
Qin, 2001, Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft, J. Immunol., 166, 2385, 10.4049/jimmunol.166.4.2385
Josien, 1999, Recombinant IFN-gamma abrogates allograft tolerance induced by donor-specific blood transfusion by restoring alloantibody production, Eur. J. Immunol., 29, 317, 10.1002/(SICI)1521-4141(199901)29:01<317::AID-IMMU317>3.0.CO;2-O